Tag: HY-091
AFT Pharmaceuticals spearheads progress in women’s health with Hyloris partnership
AFT Pharmaceuticals announced its partnership with Hyloris Pharmaceuticals, based in Belgium, to develop a novel treatment, HY-091, for Vulvar Lichen Sclerosus (VLS), addressing the critical need for effective solutions in an area where approved treatments are limited.
Featured Article
From ship repair to autonomous underwater vehicles: Griffin Industrial’s next chapter with growth capital
Some of Australia’s most critical manufacturing happens where almost no one sees it: inside a fuel tank on a Navy tanker, in a machine shop south of Perth, on a workshop floor in western Sydney where a team is helping build autonomous underwater vehicles. Griffin Industrial does all three.
